VYNE Therapeutics Stock: Clinical Risk Ahead & Questionable Business Plan (NASDAQ:VYNE)
primeimages/iStock via Getty Images Vyne Therapeutics (NASDAQ:VYNE) has announced that due to disappointing sales, they
Therapeutics
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
SEATTLE, WA / ACCESSWIRE / November 12, 2021 / Aptevo Therapeutics Inc. (“Aptevo” or the
Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan
BOSTON–(BUSINESS WIRE)–Today, Thimble Point Acquisition Corp, Inc. (NASDAQ: THMA) (“Thimble Point”), a special purpose acquisition
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Debuted as Publicly Traded Company and Raised $100 Million in Gross Proceeds to Fund Liquid
Amylyx Pharmaceuticals Strengthens Board of Directors with Appointment of Daphne Quimi, Chief Financial Officer of Amicus Therapeutics
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals today announced the addition of Daphne Quimi to its Board
Briefs on local business, including Framingham’s Youth Internship Program, SBA’s Community Navigator Pilot Program and Dyne Therapeutics,
Send news about your local business to [email protected]. We’re interested in news about business people,